Vallejo, CA4 Active Studies

Lung Cancer Clinical Trials in Vallejo, CA

Find 4 actively recruiting lung cancer clinical trials in Vallejo, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,720
Enrolling

Recruiting Lung Cancer Studies in Vallejo

RecruitingVallejo, CANCT06635824

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab versus docetaxel (standard of care) in ...

702 participants
Genmab
View Study Details
RecruitingVallejo, CANCT06305754

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squ...

520 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingVallejo, CANCT05668988

A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

This is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD9008 versus platinum-based doublet chemotherapy in participants with locally advanced or metastati...

320 participants
Dizal Pharmaceuticals
View Study Details
RecruitingVallejo, CANCT05798663

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

This is a phase II trial of neoadjuvant and adjuvant atezolizumab with or without tiragolumab in conjunction with chemoradiotherapy for unresectable stage III NSCLC....

178 participants
Alliance Foundation Trials, LLC.
View Study Details

About Lung Cancer Clinical Trials in Vallejo

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Vallejo, CA. These studies are seeking a combined 1,720 participants. Research is being sponsored by Genmab, Merck Sharp & Dohme LLC, Dizal Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Vallejo — FAQ

Are there lung cancer clinical trials in Vallejo?

Yes, there are 4 lung cancer clinical trials currently recruiting in Vallejo, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Vallejo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vallejo research site will contact you about next steps.

Are clinical trials in Vallejo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vallejo studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Vallejo are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov